Skip to main content
. 2023 Nov 6;14:419–434. doi: 10.2147/PHMT.S429321

Table 4.

Results of Bivariable Logistic Regression of Factors Associated with Bradycardia After Induction of General Anesthesia Among Pediatric Patients Operated at Hawassa University Comprehensive Specialized Hospital, Ethiopia (n=205)

Variables Categories Bradycardia After General Anesthesia, Frequency (%) COR (95% CI) P-value
Yes (n=40) No (n=165)
40 (19.5) 165 (80.5)
ASA class ASA-I 16 (11.9) 118 (88.1) 1
ASA-II 24 (33.8) 47 (66.2) 0.27 (0.13–0.54) 0.14
Preoperative risk of hypoxia (desaturation) No 12 (9.5) 114 (90.5) 1
Yes 28 (35.4) 51 (64.6) 5.22 (2.45–11.0) 0.12
Premedications Anticholinergics Yes 16 (26.7) 44 (73.3) 1
No 24 (16.6) 121 (83.4) 1.83 (0.89–3.77) 0.21
Opioids No 13 (13.9) 143 (86.1) 1
Yes 27 (69.2) 12 (30.8) 26.5 (10.9–64.2) 0.24
Others (steroids, diazepam) No 32 (18) 146 (82) 1
Yes 8 (29.6) 19 (70.4) 1.92 (0.21–1.29) 0.26
Nature of surgery Elective 20 (14.1) 122 (85.9) 1
Emergency 20 (31.7) 43 (68.5) 0.35 (0.17–0.72) 0.28
Induction of general anesthesia IV induction Yes 14 (8.9) 143 (91.1) 1
No 26 (54.2) 22 (45.8) 0.08 (0.04–0.18) 0.22
Inhalational induction No 26 (15.3) 144 (84.7) 1
Yes 14 (40) 21 (60) 3.69 (1.67–8.17) 0.10
Induction agent Ketamine Yes 12 (19.4) 50 (80.6) 1
No 28 (19.6) 115 (80.4) 0.98 (0.46–2.10) 0.36
Propofol No 24 (18.2) 108 (81.8) 1
Yes 16 (21.9) 57 (78.1) 1.26 (0.39–1.61) 0.52
Ketofol Yes 6 (11.1) 48 (88.9) 1
No 34 (22.5) 117 (77.5) 0.43 (0.17–1.09) 0.30
Halothane No 34 (17.4) 161 (82.6) 1
Yes 6 (60) 4 (40) 7.10 (1.90–26.5) 0.08
Airway management Face mask No 34 (21.4) 125 (78.6) 1
Yes 6 (13) 40 (87) 0.55 (0.22–1.41) 0.21
LMA Yes 4 (18.2) 18 (81.8) 1
No 36 (19.7) 147 (80.3) 0.91 (0.29–2.85) 0.86
ETT No 29 (38.2) 47 (61.8) 1
Yes 11 (8.5) 118 (91.5) 0.15 (0.07–0.34) 0.18
Difficult intubation No 13 (7.6) 158 (92.4) 1
Yes 27 (79.4) 7 (20.6) 46.8 (17.2–51.4) 0.02
Maintenance of anesthesia Isoflurane 11 (16.9) 54 (83.1) 1
Halothane 19 (21.6) 69 (78.4) 1.35 (0.59–3.08) 0.06
Propofol 8 (38.1) 13 (61.9) 3.02 (0.87–18.3) 0.07
Others (ketofol, ketamine) 2 (6.5) 29 (93.5) 0.34 (0.16–1.24) 0.12
Muscle relaxants used Succinylcholine 14 (66.7) 7 (33.3) 0.25 (0.36–1.15) 0.28
Vecuronium 28 (33.3) 56 (66.7) 1
Types of surgery Others (ortho, plastic, OMFS) 2 (28.6) 5 (71.4) 1
ENT 4 (36.4) 7 (63.6) 1.43 (0.25–8.16) 0.19
Urology 5 (20.8) 19 (79.2) 0.66 (0.48–16.9) 0.25
Neurosurgery 7 (22.6) 24 (77.4) 0.73 (0.22–10.3) 0.17
General surgery 13 (22) 46 (78) 0.71 (0.09–5.43) 0.23
Ophthalmological 9 (12.3) 64 (87.7) 0.35 (0.22–8.66) 0.34
Intraoperative complications No 24 (16.2) 124 (83.8) 1
Yes 16 (28.1) 41 (71.9) 2.02 (0.24–1.02) 0.16
Complications No 24 (16.2) 124 (83.8) 1
Hypoxia 5 (23.8) 16 (76.2) 1.61 (0.17–7.06) 0.15
Blood loss 2 (22.2) 7 (77.8) 1.47 (0.23–8.78) 0.16
Hypothermia 2 (18.2) 9 (81.8) 1.15 (1.9–2.90) 0.46
Hypoglycemia 3 (37.5) 5 (62.5) 3.10 (0.60–1.73) 0.22
Others (fluid load) 4 (50) 4 (50) 5.17 (1.54–4.83) 0.39

Notes: Bold p-value = Significant association on bivariable logistic regression at p-value <0.25. 1- Reference group.